The Providence Cancer Institute begins looking for COVID-19 vaccine

April 1, 2020 Providence News Team

Share this Article
Facebook
Twitter
LinkedIn

Research caregivers at the Providence Cancer Institute have switched gears from cancer and are now focusing on finding a vaccine for COVID-19, using a technique typically used for battling cancer. Dr. Bernard Fox and Dr. Rom Leidner have asked the federal government to approve their proposal for a vaccine -- although there are a lot of researchers working towards the first coronavirus vaccine, Leidner and Fox said that, as far as they know, their approach is unique.

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.
More Content by Providence News Team

The importance of flu shots in the COVID-19 era

Dr. Meade advises the public to protect themselves from everything there are vaccines for.

Hear from Dr. Medows with LinkedIn Editors

Dr. Medows gives insight into how Providence is navigating COVID-19 care.

Other content in this Stream

New vaccine being studied for HPV-positive head and neck cancers

The Providence Cancer Institute begins looking for COVID-19 vaccine

About the Author

Previous Article

Next Article

Other content in this Stream

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

Providence becomes first health system to join international endorsement of ethical use of AI.

Following Providence’s successful implementation, Community Health Network becomes Praia Health's first external customer. Praia Health welcomes sixteen health organizations to the ecosystem.

Providence’s EMR-integrated education and referral platform provides specialist expertise to front-line clinicians at the point of care.

The not-for-profit health system made significant progress in the face of ongoing challenges and invested nearly $2.1 billion in community benefit.

Former chief medical officer of Providence South Division will lead the not-for-profit health system's ambulatory operations as the new chief executive, effective Feb. 26, 2024.

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

A recent Providence study revealed that integrating a dynamic EMR order set results in improved adherence to established guidelines associated with reduction in early onset GBS neonatal sepsis.

Providence CEO Rod Hochman, M.D., releases his sixth-annual list of predictions, calling 2024 the year of health care transformation through collaboration.

The not-for-profit health system continued to serve more people while staying the course on strategies for recovery and renewal.

A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

The HL7 FHIR® standard makes clinical and administrative data available in a standardized and secure format to help reduce inefficiencies and increase quality of care.

Providence study seeks to help practitioners better identify and care for patients by providing a more comprehensive understanding of how long COVID presents and the patient experience of this disease

Free virtual therapy available to more than 15,000 students across the Renton School District

Startup veteran Justin Dearborn to serve as Executive-in-Residence for the identity-driven personalization platform

Providence achieved recognition as an Adopter of the Healthcare Financial Management Association’s PATIENT FINANCIAL COMMUNICATIONS BEST PRACTICES®.

MSSP ACO Health Connect Partners serves more than 100k beneficiaries in the Western U.S.

The not-for-profit health system continues to stay the course on strategies for recovery and renewal.

Credena Health's new 20,000-square-foot facility marks the completion of a three-year project, launching a hub for innovative pharmacy care and patient support solutions.

Researchers from Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, shared their investigations to advance cancer research and treatments at the premier event.